168 results Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Wouter den Hollander Counsel Amsterdam The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates. De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates. Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates. Ali al Khatib Senior Associate Amsterdam Frederike de Meulemeester Senior Associate Amsterdam Sofja Goldstein Senior Associate Amsterdam PFAS-regulering onder druk: wat betekenen nieuwe rechtszaken voor bedrijven en overheden? PFAS blijven de gemoederen bezighouden. Terwijl het RIVM nieuwe risico’s onderzoekt en bestuursorganen zoeken naar handhaafbare normen, groeit het aantal juridische procedures rondom deze omstreden stofgroep. Dutch Supreme Court refers questions to CJEU in trucks case On 20 June 2025, the Dutch Supreme Court referred questions to the CJEU in an antitrust damages case on trucks manufacturing. This blog explores the events leading to this pivotal moment and the key questions posed. Stibbe advises KLM and Martinair Representing KLM and its subsidiary Martinair in antitrust damage litigation in what is alleged to be Europe's largest ever cartel damage claim. Pagination Previous page Page 4 Current page 5 Page 6 Page 7 Next page
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.
De laatste Legal Updates direct in uw mailbox Dagelijks publiceren wij op onze website hoogwaardige juridische kennis en vooruitzichten. Wilt u snel op de hoogte zijn van de meest actuele ontwikkelingen binnen uw interessegebieden? Meld u dan aan voor onze Legal Updates.
Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates.
PFAS-regulering onder druk: wat betekenen nieuwe rechtszaken voor bedrijven en overheden? PFAS blijven de gemoederen bezighouden. Terwijl het RIVM nieuwe risico’s onderzoekt en bestuursorganen zoeken naar handhaafbare normen, groeit het aantal juridische procedures rondom deze omstreden stofgroep.
Dutch Supreme Court refers questions to CJEU in trucks case On 20 June 2025, the Dutch Supreme Court referred questions to the CJEU in an antitrust damages case on trucks manufacturing. This blog explores the events leading to this pivotal moment and the key questions posed.
Stibbe advises KLM and Martinair Representing KLM and its subsidiary Martinair in antitrust damage litigation in what is alleged to be Europe's largest ever cartel damage claim.